Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade

Expert Opin Drug Deliv. 2022 Feb;19(2):179-197. doi: 10.1080/17425247.2022.2041599. Epub 2022 Feb 24.

Abstract

Introduction: The development and application of novel therapeutic medicines for the treatment of cancer are of vital importance to improve the disease<apos;>s outcome and survival rate. One noteworthy treatment approach is the use of biologically active compounds present in natural products. Even though these phytocompounds present anti-inflammatory, antioxidant, and anticancer properties, their use is limited essentially due to poor systemic delivery, low bioavailability, and water solubility concerns. To make full use of the anticancer potential of natural products, these limitations need to be technologically addressed. In this sense, nanotechnology emerges as a promising drug delivery system strategy.

Areas covered: In this review, the benefits and potential of nanodelivery systems for natural products encapsulation as promising therapeutic approaches for cancer, which were developed during the last decade, are highlighted.

Expert opinion: The nanotechnology area has been under extensive research in the medical field given its capacity for improving the therapeutic potential of drugs by increasing their bioavailability and allowing a targeted delivery to the tumor site. Thereby, the nanoencapsulation of phytocompounds can have a direct impact on the recognized therapeutic activity of natural products towards cancer.

Keywords: Cancer; drug delivery systems; nanoparticles; natural products; phytochemicals.

Publication types

  • Review

MeSH terms

  • Biological Products*
  • Drug Delivery Systems
  • Humans
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy
  • Pharmaceutical Preparations
  • Phytochemicals / therapeutic use

Substances

  • Biological Products
  • Pharmaceutical Preparations
  • Phytochemicals